Jonsson, Michael
Sahlgrenska University Hospital
6 papers on CoChatORCID 0000-0001-6743-8371
Most cited papers
- Verified · note
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis
Bridel, C., van Wieringen, W. N., Zetterberg, H., Tijms, B. M., Teunissen, C. E., and the NFL Group, Alvarez-Cermeño, J. C., Andreasson, U., Axelsson, M., Bäckström, D. C., et al. (2019) · JAMA Neurology
Multiple Sclerosis Research StudiesCerebrospinal fluid and hydrocephalus
Cited by 764
- Verified
Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
Mummery, C. J., Börjesson-Hanson, A., Blackburn, D. J., Vijverberg, E. G. B., De Deyn, P. P., Ducharme, S., Jonsson, M., Schneider, A., Rinne, J. O., Ludolph, A. C., et al. (2023) · Nature Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 347
- Verified
Treatment of Alzheimer’s Disease with Clioquinol
Regland, B., Lehmann, W., Abedini, I., Blennow, K., Jonsson, M., Karlsson, I., Sjögren, M., Wallin, A., Xilinas, M., & Gottfries, C.-G. (2001) · Dementia and Geriatric Cognitive Disorders
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 220
- Verified
Neurofilament protein in cerebrospinal fluid: A marker of white matter changes
Sjögren, M., Blomberg, M., Jonsson, M., Wahlund, L. ‐., Edman, Å., Lind, K., Rosengren, L., Blennow, K., & Wallin, A. (2001) · Journal of Neuroscience Research
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 209
- Verified
Cognitive Outcomes of Long-term Benzodiazepine and Related Drug (BDZR) Use in People Living With Mild to Moderate Alzheimer's Disease: Results From NILVAD
Dyer, A. H., Murphy, C., Lawlor, B., Kennelly, S. P., Lawlor, B., Segurado, R., Kennelly, S., Olde Rikkert, M. G. M., Howard, R., Pasquier, F., et al. (2020) · Journal of the American Medical Directors Association
Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes
Cited by 39
- Verified
Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study
Jonsson, M., Zetterberg, H., Rolstad, S., Edman, A., Gouw, A. A., Bjerke, M., Lind, K., Blennow, K., Pantoni, L., Inzitari, D., et al. (2012) · Dementia and Geriatric Cognitive Disorders
Cerebrovascular and genetic disordersDementia and Cognitive Impairment Research
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free